Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.00% | 0.00% | 0.00% |
2020 | Abattis Bioceuticals Corp. Reports Earnings Results for the Full Year Ended September 30, 2019 | CI |
2019 | Abattis Bioceuticals Corp. Announces Board Changes | CI |
Sales 2018 | 8.37K 6.11K | Sales 2019 | 357K 261K | Capitalization | 8.62M 6.29M |
---|---|---|---|---|---|
Net income 2018 | -78M -56.96M | Net income 2019 | -3M -2.19M | EV / Sales 2018 | 5,778 x |
Net cash position 2018 | 9.1M 6.64M | Net cash position 2019 | 2.25M 1.64M | EV / Sales 2019 | 17.8 x |
P/E ratio 2018 |
-0.57
x | P/E ratio 2019 |
-2.8
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 99.64% |
1 day | -99.00% |
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | - | 19-03-31 | |
Patrick Mitchell
COO | Chief Operating Officer | - | 18-10-31 |
Jonathan Danieli
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Cedric Wilson
BRD | Director/Board Member | - | 18-10-18 |
Patrick Mitchell
COO | Chief Operating Officer | - | 18-10-31 |
Director of Finance/CFO | - | 19-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-03 | 0.000001 | -99.00% | 59,000 |
Delayed Quote OTC Markets, June 03, 2024 at 09:40 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
0.00% | 476 | |
-.--% | 339M | |
+23.05% | 231M | |
+5.15% | 213M | |
+32.27% | 171M | |
+125.65% | 136M | |
-28.57% | 121M | |
+30.43% | 115M | |
-48.87% | 102M | |
0.00% | 87.33M |
- Stock Market
- Equities
- ATTBF Stock